Current position:Home >Product >
Butanoic acid, 3-amino-4-[(2-hydroxyethyl)amino]-4-oxo-, phenylmethyl ester, (S)-
Butanoic acid, 3-amino-4-[(2-hydroxyethyl)amino]-4-oxo-, phenylmethyl ester, (S)-(138582-72-6)
- Name: Butanoic acid, 3-amino-4-[(2-hydroxyethyl)amino]-4-oxo-, phenylmethyl ester, (S)-
- Synonyms:
- Molecular Formula:C13H18N2O4
- Molecular Weight:266.297
- CAS Registry Number:138582-72-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.138582-72-6 Butanoic acid, 3-amino-4-[(2-hydroxyethyl)amino]-4-oxo-, phenylmethyl ester, (S)-
Assay:99.90% Appearance:solid or liquid Package:Foil bag; Drum; Plastic bottle Storage:in sealed air resistant place Transportation:by sea or air Application:Pharma;Industry;Agricultural
Min. Order:0
Supplier:Kono Chem Co.,Ltd [
China (Mainland)]
Other Product
- 138582-46-4/5(4H)-Oxazolone, 2-[2-(4,5-dihydro-4-phenyl-5-thioxo-1H-tetrazol-1-yl)-1-methylethyl]-4,4- dimethyl-
- 138582-48-6/5(4H)-Oxazolone, 4,4-dimethyl-2-[2-(2-thioxo-1(2H)-pyridinyl)ethyl]-
- 138582-49-7/2(1H)-Pyridinone, 1-[2-(4,5-dihydro-4,4-dimethyl-5-oxo-2-oxazolyl)ethyl]-
- 138582-50-0/4(1H)-Pyridinone, 1-[2-(4,5-dihydro-4,4-dimethyl-5-oxo-2-oxazolyl)ethyl]-
- 138582-51-1/5(4H)-Oxazolone, 2-[2-(2,3-dihydro-3-methyl-2-thioxo-1H-imidazol-1-yl)ethyl]-4,4-dimethyl-
- 138582-52-2/5(4H)-Oxazolone, 4,4-dimethyl-2-[2-(2-thioxo-3-thiazolidinyl)ethyl]-
- 138582-55-5/5(4H)-Oxazolone, 4,4-dimethyl-2-[2-(2-thioxo-3(2H)-benzothiazolyl)ethyl]-
- 138582-56-6/2(3H)-Benzothiazolone, 3-[2-(4,5-dihydro-4,4-dimethyl-5-oxo-2-oxazolyl)ethyl]-
- 138582-57-7/5(4H)-Oxazolone, 4,4-dimethyl-2-[2-(2-thioxo-3(2H)-benzoxazolyl)ethyl]-
- 138582-58-8/1(2H)-Phthalazinone, 2-[2-(4,5-dihydro-4,4-dimethyl-5-oxo-2-oxazolyl)ethyl]-
- 138582-59-9/1,4-Phthalazinedione, 2-[2-(4,5-dihydro-4,4-dimethyl-5-oxo-2-oxazolyl)ethyl]-2,3-dihydro-
- 138582-60-2/5(4H)-Oxazolone, 2-[2-(1H-benzimidazol-1-yl)ethyl]-4,4-dimethyl-
- 138582-61-3/6H-1,3-Oxazin-6-one, 2-[2-(1H-benzimidazol-1-yl)ethyl]-4,5-dihydro-4,4-dimethyl-
- 138582-63-5/6H-1,3-Oxazin-6-one, 2-[2-(4,5-dihydro-4-phenyl-5-thioxo-1H-tetrazol-1-yl)ethyl]-4,5-dihydro-4, 4-dimethyl-
- 138582-65-7/5(4H)-Oxazolone, 2,2'-[(2-thioxo-1H-benzimidazole-1,3(2H)-diyl)di-2,1-ethanediyl]bis[4,4- dimethyl-
- 138582-66-8/2H-Benzimidazol-2-one, 1,3-bis[2-(4,5-dihydro-4,4-dimethyl-5-oxo-2-oxazolyl)ethyl]-1,3-dihydro-
- 138582-67-9/1,2,4-Triazolidine-3,5-dione, 1,2-bis[2-(4,5-dihydro-4,4-dimethyl-5-oxo-2-oxazolyl)ethyl]-4-phenyl-
- 138582-68-0/2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-bis[2-(4,5-dihydro-4,4-dimethyl-5-oxo-2-oxazolyl)ethyl]-
- 138582-71-5/Butanoic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-4-[(2-hydroxyethyl)amino]-4-oxo -, phenylmethyl ester, (S)-
- 138582-72-6/Butanoic acid, 3-amino-4-[(2-hydroxyethyl)amino]-4-oxo-, phenylmethyl ester, (S)-
- 138582-83-9/1,1'-Biphenyl, 4-[2-[3-fluoro-4-(octyloxy)phenyl]ethyl]-4'-(2-methylbutoxy)-, (S)-
- 138582-84-0/1,1'-Biphenyl, 4-[2-[3-fluoro-4-(octyloxy)phenyl]ethyl]-4'-[(1-methylheptyl)oxy]-, (S)-
- 138582-86-2/1,1'-Biphenyl, 4-[[3-fluoro-4-(octyloxy)phenyl]ethynyl]-4'-[(1-methylheptyl)oxy]-, (S)-
- 138582-87-3/1,1'-Biphenyl, 4-(decyloxy)-4'-[[4-[(1-methylheptyl)oxy]phenyl]ethynyl]-, (S)-
- 138582-90-8/Naphtho[2,1-b]furan-6-carboxylic acid, dodecahydro-2-(2-hydroxy-1-methylpropyl)-3a,6,9a-trimethyl-, methyl ester
- 138582-94-2/Methanediamine, N,N-diethyl-N',N'-dimethyl-1-[chloro(2,2,6,6-tetramethyl-1-piperidinyl)di phosphinylidene]-
- 138583-96-7/Silane, dimethyl[[1-[6-(2-nitrophenoxy)hexyl]decyl]oxy](1,1,2-methylpropyl)-
- 138584-02-8/2,5,12(1H)-Naphthacenetrione, 6-amino-3,4,4a,12a-tetrahydro-11-hydroxy-4-[(trimethylsilyl)oxy]-
- 138584-03-9/2,5,12(1H)-Naphthacenetrione, 6-amino-3,4,4a,12a-tetrahydro-11-hydroxy-7-methoxy-4-[(trimethylsilyl) oxy]-
- 138584-06-2/Hexane, 1-isothiocyanato-5-methyl-